AVA
Atlas Venture Advisors Portfolio holdings
AUM
$424M
This Quarter Return
+15.75%
1 Year Return
+0.16%
3 Year Return
+108.89%
5 Year Return
+64.67%
10 Year Return
–
AUM
$242M
AUM Growth
+$242M
(+22%)
Cap. Flow
+$13.7M
Cap. Flow
% of AUM
5.67%
Top 10 Holdings %
Top 10 Hldgs %
100%
Holding
6
New
1
Increased
–
Reduced
–
Closed
–
Top Buys
| 1 |
BCYC
Bicycle Therapeutics
BCYC
|
$13.7M |
Top Sells
No sells this quarter
Sector Composition
| 1 | Technology | 67.98% |
| 2 | Healthcare | 30.57% |
| 3 | Communication Services | 1.45% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
CBLK
1
DELISTED
Carbon Black, Inc. Common Stock
CBLK
| $164M | 67.98% | 9,823,103 | – | – |
|
|
TBIO
2
DELISTED
Translate Bio, Inc. Common Stock
TBIO
| $49.5M | 20.5% | 3,922,008 | – | – |
|
|
BCYC
3
Bicycle Therapeutics
BCYC
$511M
| $13.7M | 5.67% | +1,362,696 | New | +$13.7M |
|
4
Viridian Therapeutics
VRDN
$1.5B
| $6.44M | 2.67% | 3,142,580 | – | – |
|
5
Larimar Therapeutics
LRMR
$310M
| $4.17M | 1.73% | 3,506,207 | – | – |
|
6
Snap
SNAP
$12.1B
| $3.51M | 1.45% | 245,076 | – | – |
|